For millions of Americans who suffer from moderate to severe depression—and millions more around the world—existing drug therapies don't provide adequate treatment. For some, the drugs simply don't work; for others, the drugs treat their depression, but their side effects are so debilitating that the cure is worse than the disease. Now, Neuronetics Inc. , a Philadelphia-based medical device company, says it has a new approach to depression treatment, one based on the focused delivery of magnetic energy, that works for these otherwise untreatable patients. More importantly, the company claims, it now has the data to prove it.
Neuronetics' NeuroStar TMS (transcranial-magnetic stimulation) therapy system is a non-invasive therapy that can, says Bruce Shook, the company's president and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?